Intriguingly, PD patient-derived iPSCs harboring the LRRK2 (G2019S) mutation exhibit progressive lamin B1/B2 loss in neural stem cells (NSCs), accompanied by nuclear envelope folding defects (Liu et al., 2012). This evidence concerns the gene LRRK2 and Parkinson disease.